On Monday, plaintiffs’ lawyers filed their opening brief asking the U.S. Court of Appeals for the Fourth Circuit to reinstate more than 100 lawsuits alleging Merck’s HPV vaccine Gardasil caused ...

Since 2006, about 8 million females in the U.S. have received at least one shot of Gardasil, according to the vaccine’s maker, Merck & Co. of Whitehouse Station, N.J., which based these ...

Gardasil is "100 percent" effective against HPV five years after vaccination, according to Haupt, and Merck is studying whether its efficacy lasts longer than that.

Merck's Gardasil, the human papillomavirus vaccine to prevent cervical cancer, was shown to be safe in the second large-scale study in the past year of side effects since the drug was approved six ...

China’s first domestically made nine-valent HPV vaccine, a direct competitor to Merck’s Gardasil 9, is being priced at 499 ...

Gardasil, one of two HPV vaccines, is already approved in boys to prevent anal and penile cancers, but because these diseases are rare, only 1% actually get it.

Many parents are gripped by doubt about the safety of Gardasil, the 3-dose vaccine that promises to protect against cancer-causing HPV infections, following media reports this week on government ...

Gardasil 9 was approved in 2014. Hawaii, Rhode Island, Virginia and the District of Columbia have varying laws requiring HPV vaccines for school entry, generally for middle schoolers.

Lacking key information about Gardasil in boys, experts are adopting a wait-and-see attitude towards the drug until the FDA and some professional societies make formal recommendations for Gardasil ...

Merck & Co. tested its Gardasil vaccine so it can seek approval to market the vaccine for two new uses, blocking cervical cancer in women over age 26 and preventing anal cancer in homosexual men.

Looking at the numbers Merck is posting for sales of its cervical-cancer vaccine Gardasil, the Health Blog can't help but wonder whether Merck really needed to even try its controversial lobbying ...